330P Real-world treatment (tx) outcomes of durvalumab (D)-based regimens in advanced biliary tract cancer (aBTC): LIVER-R interim analysis (IA)
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.05.345
Austin Health(AU)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
45
Citations
1
h-index
1
i10-index
N.C. Tebbutt is an academic researcher from Austin Health. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer & Cancer Cells and Metastasis. The author has an h-index of 1, co-authored 5 publications.
Click to start Chat